H.R.3873 - Knock Out Cancer Act; KO Cancer Act (119th Congress)
Summary
H.R.3873, the Knock Out Cancer Act (KO Cancer Act), aims to increase funding for cancer research by the National Cancer Institute (NCI). The bill proposes to appropriate an amount equal to 25% of the NCI's 2022 fiscal year budget for each of the fiscal years 2026 through 2030, in addition to existing appropriations. It also mandates a study and report to Congress on the reasons for cancer drug shortages.
Expected Effects
If enacted, the bill would significantly increase funding for cancer research at the NCI. This could accelerate the development of new treatments, therapies, and potentially cures for cancer. The study on drug shortages could lead to policy changes that improve access to cancer drugs.
Potential Benefits
- Increased funding for cancer research, potentially leading to breakthroughs in treatment and prevention.
- Earlier detection of cancer through increased awareness.
- Improved survival rates for cancer patients.
- Addressing cancer drug shortages, ensuring patients have access to necessary medications.
- Strengthened role of the National Cancer Institute as a leader in cancer research.
Most Benefited Areas:
Potential Disadvantages
- Increased government spending, potentially contributing to the national debt.
- Potential for inefficient allocation of funds if not managed effectively.
- The bill does not specify the source of funding, which could lead to cuts in other important programs.
- The study on drug shortages may not lead to effective solutions.
- Increased funding may not directly translate to cures or significant improvements in survival rates.
Most Disadvantaged Areas:
Constitutional Alignment
The bill aligns with the Constitution's mandate to "promote the general Welfare" (Preamble). Congress has the power to appropriate funds for specific purposes, as outlined in Article I, Section 8, which grants Congress the power to lay and collect taxes, duties, imposts and excises, to pay the debts and provide for the common defense and general welfare of the United States. The bill's focus on cancer research falls under the umbrella of promoting public health, which is a legitimate function of the federal government.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).